Perspective Therapeutics, Inc. Share Price
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Delayed
NYSE
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.130 USD | +0.32% |
|
+0.64% | +13.82% |
| 08-19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 08-14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
| Market Cap | 357M 307M 289M 264M 494M 33.73B 496M 3.42B 1.33B 17.31B 1.34B 1.31B 55.76B | P/E 2026 * |
-3.13x | P/E 2027 * | -2.97x |
|---|---|---|---|---|---|
| Enterprise Value | 191M 164M 154M 141M 264M 18.01B 265M 1.82B 708M 9.24B 716M 701M 29.77B | EV / Sales 2026 * |
569x | EV / Sales 2027 * | 319x |
| Free-Float |
89.27% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CATX | Delayed | |
CBOE
| CATX | Real-time | |
|
Tradegate
| AAJ0 | Real-time | |
|
Boerse Muenchen
| AAJ0 | Real-time | |
|
Deutsche Boerse AG
| AAJ0 | Delayed | |
|
Börse Stuttgart
| AAJ0 | Delayed |
Last Transcript : Perspective Therapeutics, Inc.
| 1 day | +0.32% | ||
| 1 week | +0.64% | ||
| Current month | -0.95% | ||
| 1 month | +5.39% | ||
| 3 months | +3.30% | ||
| 6 months | -37.02% | ||
| Current year | +13.82% |
| 1 week | 3.02 |  | 3.24 |
| 1 month | 2.94 | | 3.56 |
| Current year | 2.25 | | 6.16 |
| 1 year | 1.96 | | 6.16 |
| 3 years | 1.6 | | 19.05 |
| 5 years | 1.6 | | 19.05 |
| 10 years | 1.6 | | 28.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 54 | 04/02/2023 |
Joel D. Sendek
DFI | Director of Finance/CFO | 59 | 03/09/2025 |
Paul Lyne
CTO | Chief Tech/Sci/R&D Officer | - | 07/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Johan Spoor
BRD | Director/Board Member | 54 | 04/02/2023 |
Lori Woods
CHM | Chairman | 63 | 02/02/2023 |
| Director/Board Member | 60 | 04/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Sell | Company | -35,769 | 0.0313% | ||
| 31/08/26 | Sell | Company | -78,145 | 0.0685% | ||
| 02/03/26 | Free | Director | 50,000 | 0.0439% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.32% | +0.64% | -9.54% | -20.68% | 357M | |
| -0.88% | -2.50% | -1.40% | +14.18% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | |
| -0.96% | -2.31% | +15.75% | +45.41% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | |
| -1.54% | -1.30% | +12.02% | +31.14% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | |
| Average | -0.83% | +0.50% | +64.47% | +95.45% | 27.54B | |
| Weighted average by Cap. | -0.95% | +0.05% | +89.10% | +128.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 335K 289K 272K 248K 464K 31.67M 465K 3.21M 1.25M 16.25M 1.26M 1.23M 52.35M | 396K 341K 321K 293K 548K 37.41M 550K 3.79M 1.47M 19.19M 1.49M 1.46M 61.83M |
| Net income | -116M -99.45M -93.57M -85.48M -160M -10.91B -160M -1.11B -429M -5.6B -434M -425M -18.04B | -135M -116M -110M -100M -187M -12.77B -188M -1.29B -502M -6.55B -508M -497M -21.11B |
| Net Debt | -167M -143M -135M -123M -230M -15.73B -231M -1.59B -618M -8.07B -625M -612M -25.99B | -231M -199M -187M -171M -319M -21.8B -320M -2.21B -857M -11.18B -867M -848M -36.03B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$3.130 | +0.32% | 1,365,189 |
| 03/09/26 | US$3.120 | +0.65% | 931,703 |
| 02/09/26 | US$3.100 | 0.00% | 864,638 |
| 01/09/26 | US$3.100 | -1.90% | 705,838 |
| 31/08/26 | US$3.160 | +1.61% | 910,730 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CATX Stock
Select your edition
All financial news and data tailored to specific country editions
